Corrigendum: Cerebral Cavernous Malformations: Review of the Genetic and Protein–Protein Interactions Resulting in Disease Pathogenesis
暂无分享,去创建一个
M. Yashar S. Kalani | J. Baranoski | M. Kalani | J. Zabramski | Jacob F. Baranoski | Joseph M. Zabramski | Colin J. Przybylowski | C. Przybylowski
[1] M. Malbouyres,et al. CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling , 2013, The Journal of cell biology.
[2] W. Min,et al. EXCEPTIONAL AGGRESSIVENESS OF CEREBRAL CAVERNOUS MALFORMATION DISEASE ASSOCIATED WITH PDCD10 MUTATIONS , 2014, Genetics in Medicine.
[3] T. Haystead,et al. Proteomic identification of the cerebral cavernous malformation signaling complex. , 2007, Journal of proteome research.
[4] A. Louvi,et al. Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration , 2014, Development.
[5] C. Liquori,et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.
[6] F. Garaci,et al. Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene , 2015, The neuroradiology journal.
[7] M. Ginsberg,et al. Rap1 and its effector KRIT1/CCM1 regulate β-catenin signaling , 2010, Disease Models & Mechanisms.
[8] R. Shenkar,et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.
[9] R. Scott,et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. , 1998, Human molecular genetics.
[10] Lan Cheng,et al. Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. , 2012, Developmental cell.
[11] W. Min,et al. Molecular Recognition of Leucine-Aspartate Repeat (LD) Motifs by the Focal Adhesion Targeting Homology Domain of Cerebral Cavernous Malformation 3 (CCM3)* , 2011, The Journal of Biological Chemistry.
[12] W. Min,et al. Crystal Structure of CCM3, a Cerebral Cavernous Malformation Protein Critical for Vascular Integrity* , 2010, The Journal of Biological Chemistry.
[13] T. Boggon,et al. Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C‐terminus , 2013, FEBS letters.
[14] L. Ferrarini,et al. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice , 2015, Proceedings of the National Academy of Sciences.
[15] Melynda Boerm,et al. Mekk3 is essential for early embryonic cardiovascular development , 2000, Nature Genetics.
[16] P. Degan,et al. KRIT1 Regulates the Homeostasis of Intracellular Reactive Oxygen Species , 2010, PloS one.
[17] Christopher A. Jones,et al. The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.
[18] A. Benz,et al. Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins. , 2015, Developmental cell.
[19] U. Felbor,et al. Highly variable intrafamilial manifestations of a CCM3 mutation ranging from acute childhood cerebral haemorrhage to late-onset meningiomas , 2015, Clinical Neurology and Neurosurgery.
[20] F. Chapon,et al. CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas , 2013, Molecular Syndromology.
[21] J. Weber,et al. Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig. , 1995, Genome research.
[22] L. Morrison,et al. Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1 , 2016, Free radical biology & medicine.
[23] L. Morrison,et al. A locus for cerebral cavernous malformations maps to chromosome 7q in two families. , 1995, Genomics.
[24] Ying Zhang,et al. Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3. , 2015, Structure.
[25] Ulrich Sure,et al. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling , 2010, Proceedings of the National Academy of Sciences.
[26] T. Mayadas,et al. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3 , 2015, Proceedings of the National Academy of Sciences.
[27] M. Preul,et al. Cerebral cavernous malformations : from genes to proteins to disease Clinical article , 2011 .
[28] E. Tournier-Lasserve,et al. Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes , 2015, Stroke.
[29] I. Awad,et al. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. W. Thomas,et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). , 1999, Human molecular genetics.
[31] N. Sciaky,et al. Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells , 2009, Journal of Biological Chemistry.
[32] M. Ginsberg,et al. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions , 2007, The Journal of cell biology.
[33] R. Fulton,et al. A human chromosome 7 yeast artificial chromosome (YAC) resource: construction, characterization, and screening. , 1995, Genomics.
[34] R. Fässler,et al. Disruption of Focal Adhesions by Integrin Cytoplasmic Domain-associated Protein-1α* , 2003, The Journal of Biological Chemistry.
[35] M. Ginsberg,et al. Structural basis of the junctional anchorage of the cerebral cavernous malformations complex , 2012, The Journal of cell biology.
[36] W. Sessa,et al. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. , 2010, The Journal of clinical investigation.
[37] G. Johnson,et al. Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling , 2013, Biological chemistry.
[38] J. Mably,et al. ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway. , 2013, Developmental biology.
[39] Wei Pan,et al. Cerebral Cavernous Malformations Arise Independent of the Heart of Glass Receptor , 2014, Stroke.
[40] R. Pallini,et al. Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition , 2016, Stroke.
[41] J. Testa,et al. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22 , 1997, Oncogene.
[42] Andrea Mosca,et al. PDCD10 Gene Mutations in Multiple Cerebral Cavernous Malformations , 2014, PloS one.
[43] Dean Y. Li,et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. , 2015, Developmental cell.
[44] T. Boggon,et al. CCM2–CCM3 interaction stabilizes their protein expression and permits endothelial network formation , 2015, The Journal of cell biology.
[45] N. Sciaky,et al. Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype* , 2010, The Journal of Biological Chemistry.
[46] M. Clanet,et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.
[47] P. Frérebeau,et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. , 2004, American journal of human genetics.
[48] A. Joutel,et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas , 1999, Nature Genetics.
[49] T. Boggon,et al. Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. , 2013, Molecular cell.